|
1. Biologie
|
|
|
|
2. Etiologie
|
|
|
|
3.1.1 Prévention - Tabac - e-cigs
|
|
|
|
|
3.4.1 Chimioprévention - aspirine
|
|
|
|
|
|
5. Traitements
|
|
|
Making chemotherapy kinder for childhood leukaemia [Cancer Research UK]
|
|
|
|
|
|
But
interestingly, my results showed that although children on each dose
were given the same amount of dexamethasone for their size, the
concentration in their bodies varied dramatically. It suggests that
children are processing the drug differently, which may help to explain
why no difference was seen between the two doses.
|
|
|
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
5.12.2 Immunothérapies - CAR-T, thérapies cellulaires
|
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA,...)
|
|
|
|
6. Lutte contre les cancers
|
|
|
Ten years after the economic crash, R&D funding is better than ever [Nature]
|
|
|
|
|
|
In
nations such as Germany, Denmark and the United Kingdom, which have
strong economies and innovation sectors, R&D funding levels remained
robust in both the public and private sectors. Germany, for example,
has increased its public funding by 46% since 2008, from US$23 billion
to $34 billion in 2016.
|
|
|
|
|
|
|
6.1 Observation
|
|
|
|
6.11 Patients
|
|
|
|
6.12 Ethique
|
|
|
|
|
Why do medical journals keep taking authors at their word? [STAT]
|
|
|
|
|
|
It
seems clear, then, that it is time to take this responsibility away
from journals, or at least add another layer. What’s needed is a single
pool of conflicts data — one that captures cash payments, patents, stock
holdings, board seats (both corporate and foundations), funding sources
for research — against which editors can screen authors.
|
|
|
|
|
|
|
6.2 Implants mammaires
|
|
|
|
6.3 Associations/Fondations
|
|
|
|
6.6 Publications
|
|
|
|
|
6.9 Controverses
|
|
|
|
Evidence-based medicine group in turmoil after expulsion of co-founder [Science]
|
|
|
|
|
|
Gøtzsche
helped found the organization in 1993 and started the Nordic Cochrane
Center in Denmark that same year. Today, Cochrane has a network of many
thousands of volunteer reviewers as well as independent Cochrane Groups
in 43 countries; it does not accept industry money but is supported
primarily by government agencies, including the U.S. National Institutes
of Health and the U.K. National Institute for Health Research.
|
|
|
|
|
|